Davis Capital Management
NEO icon

Davis Capital Management’s NeoGenomics NEO Stock Holding History

Davis Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$129 Hold
7
– – ﹤0.01% 975
2026
Q2 		$102 Buy
+7
New +$68 ﹤0.01% 1059

Other funds holding NEO

Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Moody National Bank Trust Division
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Davis Capital Management's NEO Position: Q3 2026 in Review

Davis Capital Management held its NeoGenomics (NEO) position steady in Q3 2026 at 7 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Davis Capital Management first reported a position in NEO in Q2 2026 and has held it in 2 quarters since. 62 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Davis Capital Management held 7 shares of NeoGenomics worth $129 as of Q3 2026.
  • Davis Capital Management left its NeoGenomics share count unchanged in Q3 2026.
  • NeoGenomics made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #975 holding.
  • Davis Capital Management first reported a position in NeoGenomics in Q2 2026 and has held it in 2 quarters since.
  • 62 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.